clinical trials

Recent Rosacea Blog Posts

Omiganan still in the rosacea pipeline

There aren’t many drugs currently in late development for rosacea. Finacea foam and Soolantra have been approved, and it looks like Azultro is on the way. One of the remaining drugs that is still inching its way through the approval process is Omiganan. Confirmation that Omiganan is still alive in the rosacea development pipeline comes from […]

Continue Reading

Stanford continuing Genetic link to Rosacea

Last year a group of researchers from Stanford University and 23andMe, lead by Dr. Anne Chang published some ground breaking discoveries relating to 2 genes that looked like they might be related to rosacea symptoms. The findings were described by Stanford; Genetic basis of rosacea identified by researchers The researchers compared the genomes of rosacea […]

Continue Reading

Finacea vs. Metrogel and Mirvaso–Fight!

A recently listed Clinical Trial aims to recruit rosacea sufferers to find out how well they are getting on with their usage of Finacea, Metrogel and Mirvaso. The trial outcomes are several, but include the recording of adverse reactions to treatments, patient satisfaction and likelihood of switching rosacea treatment. The trial is being sponsored by […]

Continue Reading

A clinical research company has posted a large clinical trial to compare a Metronidazole 1% Gel to Galderma’s Metrogel 1%. The multi center trial is looking for 947 participants across the US. The manufacturer of the comparison Metronidazole 1% Gel is not mentioned, but a reasonable guess would be Metronidazole Gel from Sandoz. Generic Metronidazole […]

Continue Reading

Actavis to trial Mirvaso competitor

An interesting development in rosacea clinical trials is the emergence of a new company called Actavis. Actavis have listed a large trial where they plan to test their Brimonidine Gel against Galderma’s recently FDA approved Brimonidine-based Mirvaso Gel. The large Phase 3 trial will compare the response after 7 days. Up to 462 patients in […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.